Axonics Modulation Technologies, Inc. (AXNX): Price and Financial Metrics
GET POWR RATINGS... FREE!
AXNX Stock Price Chart Interactive Chart >
AXNX Price/Volume Stats
|Current price||$69.70||52-week high||$79.81|
|Prev. close||$69.78||52-week low||$41.13|
|Day high||$70.07||Avg. volume||549,680|
|50-day MA||$69.25||Dividend yield||N/A|
|200-day MA||$59.31||Market Cap||3.22B|
Axonics Modulation Technologies, Inc. (AXNX) Company Bio
Axonics Modulation Technologies, Inc. is a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation (SNM) solutions. The company focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in 2013 and is headquartered in Irvine, CA.
Most Popular Stories View All
AXNX Latest News Stream
|Loading, please wait...|
AXNX Latest Social Stream
View Full AXNX Social Stream
Latest AXNX News From Around the Web
Below are the latest news stories about Axonics Inc that investors may wish to consider to help them evaluate AXNX as an investment opportunity.
Axonics (AXNX) announces European CE Mark approval of its second generation Axonics r-SNM implantable neurostimulator ((INS)) and wireless patient remote control with SmartMRI technology. Axonics previously received FDA approval for this INS and remote control during 2020. This version reduces how frequently a patient needs to recharge their sacral neuromodulation device...
Axonics (AXNX) has priced its public offering of 3.5M common shares at $50.00/share, for expected gross proceeds of $175M.Underwriters' over-allotment is an additional 525K shares. Net proceeds will be used to repay outstanding indebtedness, for commercialization purpose, R&D activities, working capital and general corporate purposes.Closing date is May 14.Shares down 4.6% after-hours.Previously...
AXNX Price Returns
Continue Researching AXNXWant to see what other sources are saying about Axonics Modulation Technologies Inc's financials and stock price? Try the links below:
Axonics Modulation Technologies Inc (AXNX) Stock Price | Nasdaq
Axonics Modulation Technologies Inc (AXNX) Stock Quote, History and News - Yahoo Finance
Axonics Modulation Technologies Inc (AXNX) Stock Price and Basic Information | MarketWatch